EXAS — Exact Sciences Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousLarge CapNeutral

Annual cashflow statement for Exact Sciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-849	-596	-624	-204	-1,029
Depreciation
Amortisation
Deferred Taxes
Non-Cash Items	874	455	241	155	1,091
Unusual Items
Other Non-Cash Items
Changes in Working Capital	-42.7	111	-26.4	-0.342	-56
Change in Accounts Receivable
Change in Inventories
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Cash from Operating Activities	136	-102	-224	156	211
Capital Expenditures	-476	-194	-214	-125	-181
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Software Development Costs
Other Investing Cash Flow Items	-226	-888	289	174	-261
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-702	-1,082	74.1	49.7	-442
Financing Cash Flow Items	15.3	17.8	20	18.6	13.5
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	1,880	8.47	76.5	160	232
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	1,314	-1,176	-73	367	-3.04